Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis-Reference-Cited by-同舟云学术

Differences in Prognosis and Recurrence Patterns Between Ulcerative Colitis-Associated Colorectal Cancer and Sporadic Colorectal Cancer: A Matched-Pair Analysis

Published:2024-09-07 Issue: Volume: Page:
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kobayashi Kei,Toritani Kenichiro,Kimura Hideaki,Kawashima Jun,Goto Koki,Suwa Yusuke,Ozawa Mayumi,Ishibe Asushi,Watanabe Jun,Endo Itaru

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1245/s10434-024-16158-z.pdf

Reference48 articles.

1. Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(2):313–21. https://doi.org/10.1053/j.gastro.2016.10.020.

2. Jess T, Horvath-Puho E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: A Danish population-based cohort study. Am J Gastroenterol. 2013;108(12):1869–76. https://doi.org/10.1038/ajg.2013.249.

3. Kappelman MD, Farkas DK, Long MD, et al. Risk of cancer in patients with inflammatory bowel diseases: A nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol. 2014;12(2):265–73. https://doi.org/10.1016/j.cgh.2013.03.034.

4. Hrabe JE, Byrn JC, Button AM, Zamba GK, Kapadia MR, Mezhir JJ. A matched case-control study of IBD-associated colorectal cancer: IBD portends worse outcome. J Surg Oncol. 2014;109(2):117–21. https://doi.org/10.1002/jso.23465.

5. Gearhart SL, Nathan H, Pawlik TM, Wick E, Efron J, Shore AD. Outcomes from IBD-associated and non-IBD-associated colorectal cancer: A Surveillance Epidemiology and End Results Medicare study. Dis Colon Rectum. 2012;55(3):270–7. https://doi.org/10.1097/DCR.0b013e318242620f.